Cyclosporin compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S317000, C514S912000, C514S975000, C435S112000

Reexamination Certificate

active

11255821

ABSTRACT:
A composition is disclosed herein comprising from about 0.001% to about 0.4% cyclosporin A, castor oil, and a surfactant selected from the group consisting of alcohol ethoxylates, alcohols, alkyl glycosides, alkyl polyglycosides, alkylphenol ethoxylates, amine oxides, block polymers, carboxylated alcohol or alkylphenol ethoxylates, carboxylic acids/fatty acids, cellulose derivatives, ethoxylated alcohols, ethoxylated alkylphenols, ethoxylated aryl phenols, ethoxylated fatty acids, ethoxylated fatty acids, ethoxylated fatty esters and oils, fatty alcohols, fatty esters, glycol esters, lanolin-based derivatives, lecithin and lecithin derivatives, lignin and lignin derivatives, methyl esters, monoglycerides and derivatives, phosphalipids, polyacrylic acids, polyethylene glycols, polyethylene oxide-polypropylene oxide copolymers, polyethylene oxides, polymeric surfactants, polypropylene oxides, propoxylated alcohols, propoxylated alkyl phenols, propoxylated fatty acids, protein-based surfactants, sarcosine derivatives, silicone-based surfactants, sorbitan derivatives, stearates, sucrose and glucose esters and derivatives, and combinations thereof.

REFERENCES:
patent: 4388229 (1983-06-01), Fu
patent: 4388307 (1983-06-01), Cavanak
patent: 4649047 (1987-03-01), Kaswan
patent: 4814323 (1989-03-01), Andrieu et al.
patent: 4839342 (1989-06-01), Kaswan
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5047396 (1991-09-01), Orban et al.
patent: 5051402 (1991-09-01), Kurihara et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5474979 (1995-12-01), Ding et al.
patent: 5543393 (1996-08-01), Kim et al.
patent: 5614491 (1997-03-01), Walch et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5652212 (1997-07-01), Cavanak et al.
patent: 5759997 (1998-06-01), Cavanak
patent: 5766629 (1998-06-01), Cho et al.
patent: 5798333 (1998-08-01), Sherman
patent: 5827822 (1998-10-01), Floc'h et al.
patent: 5834017 (1998-11-01), Cho et al.
patent: 5891846 (1999-04-01), Ishida et al.
patent: 5916589 (1999-06-01), Hauer et al.
patent: 5951971 (1999-09-01), Kawashima et al.
patent: 5962014 (1999-10-01), Hauer et al.
patent: 5962017 (1999-10-01), Hauer et al.
patent: 5962019 (1999-10-01), Cho et al.
patent: 5977066 (1999-11-01), Cavanak
patent: 6007840 (1999-12-01), Hauer et al.
patent: 6024978 (2000-02-01), Hauer et al.
patent: 6057289 (2000-05-01), Mulye
patent: 6159933 (2000-12-01), Sherman
patent: 6197335 (2001-03-01), Sherman
patent: 6254860 (2001-07-01), Garst
patent: 6254885 (2001-07-01), Cho et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6284268 (2001-09-01), Mishra et al.
patent: 6294192 (2001-09-01), Patel et al.
patent: 6306825 (2001-10-01), Cavanak
patent: 6350442 (2002-02-01), Garst
patent: 6420355 (2002-07-01), Richter et al.
patent: 6468968 (2002-10-01), Cavanak et al.
patent: 6475519 (2002-11-01), Meinzer et al.
patent: 6486124 (2002-11-01), Olbrich et al.
patent: 6569463 (2003-05-01), Patel et al.
patent: 6582718 (2003-06-01), Kawashima et al.
patent: 6582826 (2003-06-01), Kawashima et al.
patent: 6638522 (2003-10-01), Mulye
patent: 6656504 (2003-12-01), Bosch et al.
patent: 6723339 (2004-04-01), Meinzer et al.
patent: 6916785 (2005-07-01), Patel
patent: 2001/0003589 (2001-06-01), Neuer et al.
patent: 2001/0036449 (2001-11-01), Garst
patent: 2002/0012680 (2002-01-01), Patel et al.
patent: 2002/0013272 (2002-01-01), Cavanak et al.
patent: 2002/0016290 (2002-02-01), Floc'h et al.
patent: 2002/0016292 (2002-02-01), Richter et al.
patent: 2002/0025927 (2002-02-01), Olbrich et al.
patent: 2002/0045601 (2002-04-01), Kawashima et al.
patent: 2002/0107183 (2002-08-01), Petswzulat et al.
patent: 2002/0119190 (2002-08-01), Meinzer et al.
patent: 2002/0165134 (2002-11-01), Richter et al.
patent: 2003/0060402 (2003-03-01), Cavanak et al.
patent: 2003/0133984 (2003-07-01), Ambuhl et al.
patent: 2003/0143250 (2003-07-01), Hauer et al.
patent: 2003/0147954 (2003-08-01), Yang et al.
patent: 2003/0166517 (2003-09-01), Fricker et al.
patent: 2003/0211983 (2003-11-01), Petszulat et al.
patent: 2003/0215496 (2003-11-01), Patel et al.
patent: 2004/0048789 (2004-03-01), Patel
patent: 2004/0101552 (2004-05-01), Patel
patent: 2004/0102366 (2004-05-01), Patel
patent: 2004/0161458 (2004-08-01), Meinzer et al.
patent: 2004/0167063 (2004-08-01), Cavanak et al.
patent: 2004/0198645 (2004-10-01), Ambuhl et al.
patent: 2005/0048087 (2005-03-01), Posanski
patent: 2005/0059583 (2005-03-01), Acheampong et al.
patent: 2005/0118254 (2005-06-01), Choi et al.
patent: 2005/0129718 (2005-06-01), Sherman
patent: 2005/0147659 (2005-07-01), Carli et al.
patent: 0471293 (1992-02-01), None
patent: WO 00/00179 (2000-01-01), None
www.lipochemicals.com document on Emulsifiers and Emulsifying systems (Aug. 20, 2002).
Uniqema, Tween™ Series. Polyoxyethylene derivatives of sorbitan esters. 2 pages.
Emulsifiers and Emulsifying Systems, Lipowax® Emulsifying Waxes, 6 pages.
RITA, Ritabate 40, INCI Nomenclature (formerly CTFA) . . . Polysorbate 40, 1 page.
RITA, Ritabate 60, INCI Nomenclature (formerly CTFA) . . . Polysorbate 60, 1 page.
RITA, Ritabate 20, INCI Nomenclature (formerly CTFA) . . . Polysorbate 20, 1 page.
TheMerckIndex Results-Form View, Monograph No. 07664, Title: Polysorbates, 1 page.
Kuwano et al, “Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits”, Pharmaceutical Research, vol. 19, No. 1, Jan. 2002, 108-111.
Restasis® (cyclosporine ophthalmic emulsion)0.05%, Sterle, Preservative-Free (Package Insert), 2 pages.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclosporin compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3881735

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.